Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wakana Saso

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cell Chemical Biology|May 22, 2018
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular EntryToby Passioura, Koichi Watashi, Kento Fukano, et al.
Plos Biology|July 31, 2020
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemmaShoya Iwanami, Kosaku Kitagawa, Hirofumi Ohashi, et al.
Plos Pathogens|June 14, 2022
Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2Wakana Saso, Masako Yamasaki, Shin-Ichi Nakakita, et al.
International Journal of Molecular Sciences|April 3, 2021
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In VitroHirofumi Ohashi, Feng Wang, Frank Stappenbeck, et al.
Biochemical and Biophysical Research Communications|May 7, 2018
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interactionWakana Saso, Senko Tsukuda, Hirofumi Ohashi, et al.
Frontiers in Microbiology|May 17, 2021
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor <i>in vitro</i>Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, et al.
The Journal of Biological Chemistry|December 15, 2019
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal networkMasashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2019
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalizationMasashi Iwamoto, Wakana Saso, Ryuichi Sugiyama, et al.
Antiviral Research|August 24, 2024
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNAMasako Yamasaki, Wakana Saso, Takuya Yamamoto, et al.
Scientific Reports|February 11, 2018
Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptideManabu Kaneko, Yushi Futamura, Senko Tsukuda, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Chemical Biology|May 22, 2018
De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular EntryToby Passioura, Koichi Watashi, Kento Fukano, et al.
Plos Biology|July 31, 2020
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemmaShoya Iwanami, Kosaku Kitagawa, Hirofumi Ohashi, et al.
Plos Pathogens|June 14, 2022
Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2Wakana Saso, Masako Yamasaki, Shin-Ichi Nakakita, et al.
International Journal of Molecular Sciences|April 3, 2021
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In VitroHirofumi Ohashi, Feng Wang, Frank Stappenbeck, et al.
Biochemical and Biophysical Research Communications|May 7, 2018
A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interactionWakana Saso, Senko Tsukuda, Hirofumi Ohashi, et al.
Frontiers in Microbiology|May 17, 2021
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor <i>in vitro</i>Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, et al.
The Journal of Biological Chemistry|December 15, 2019
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal networkMasashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2019
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalizationMasashi Iwamoto, Wakana Saso, Ryuichi Sugiyama, et al.
Antiviral Research|August 24, 2024
Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNAMasako Yamasaki, Wakana Saso, Takuya Yamamoto, et al.
Scientific Reports|February 11, 2018
Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptideManabu Kaneko, Yushi Futamura, Senko Tsukuda, et al.
Pageof 2